Hong Y, Lee JH, Jeong KW, Choi CS, Jun HS
Anecdotal evidence does not show any immediate adverse effects
8 Its the same drug as the Wegovy injection, so it mainly suits people who would prefer a daily tablet to a weekly injection, rather than those looking for the most weight loss
The implications are significant: these results raise the possibility that semaglutide may have insufficient central target engagement at the doses used, that the pharmacodynamic effect on AD-relevant pathways may be inadequate, or that targeting metabolic and inflammatory pathways may represent a fundamental limitation when applied to established amyloid-driven Alzheimers disease
Dosing protocols, treatment regimens, and administration instructions are out of scope and not provided in any form